Atp Assays Market Size Projected to Reach $7.67 billion by 2034 | 7.98%

According to Straits Research, the global ATP assays market size was valued at $3.86 billion in 2025 and is projected to grow from $4.15 billion in 2026 to $7.67 billion by 2034, registering a CAGR of 7.98% during the forecast period 2026–2034.

Market Dynamics

The ATP assays market is driven by rising adoption of luminescence- and enzyme-based ATP detection tools in drug discovery programs, where researchers rely on ATP quantification to evaluate cell viability, compound activity, and metabolic shifts across high-throughput screening platforms. A restraint affecting the market is the challenge of ATP instability during sample storage and extended handling, which creates variability in test outcomes and limits broader use in settings where rapid sample preparation is difficult to maintain. An opportunity emerges from the growing development of automated ATP assay platforms that streamline workflows across distributed laboratory networks, enabling coordinated research programs, multi-center testing, and wider use of ATP-based measurements in both clinical and industrial environments.

Market Segments

1. By Type (2026-2034)
   1. Luminometric ATP Assays
   2. Enzymatic ATP Assays
   3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
   4. Cell-based ATP Assays
   5. Others
2. By Application (2026-2034)
   1. Clinical Diagnostics
   2. Drug Discovery and Development
   3. Others
3. By End User (2026-2034)
   1. Pharmaceutical and Biotechnology Companies
   2. Clinical Diagnostics Laboratories
   3. Others